Keqp\u00ebrdorimi i antibiotik\u00ebve mbetet ende nj\u00eb problematik\u00eb e mjaft e mpreht\u00eb n\u00eb vendin ton\u00eb. Nj\u00eb gj\u00eb e till\u00eb ka ndodhur edhe me barnat e klas\u00ebs s\u00eb Kinoloneve dhe Flourkinoloneve, p\u00ebr t\u00eb cilat Agjencia Evropiane e Barnave (EMA) ka rivler\u00ebsuar efektet e pad\u00ebshiruara t\u00eb shfaqura n\u00eb sh\u00ebndet nga p\u00ebrdorimi i tyre. P\u00ebrkundrejt vler\u00ebsimeve t\u00eb b\u00ebra, \u00ebsht\u00eb k\u00ebrkuar kufizimi i p\u00ebrdorimit t\u00eb k\u00ebtyre antibiotik\u00ebve.<\/p>\n
Nd\u00ebrkoh\u00eb q\u00eb nj\u00eb problematik\u00eb e till\u00eb \u00ebsht\u00eb konfirmuar edhe disa vite m\u00eb par\u00eb n\u00eb gazet\u00ebn \u201cDita\u201d, nga doktori urolog Prof. Kim Drasa, i cili u b\u00ebnte thirrje pacient\u00ebve q\u00eb t\u00eb mos p\u00ebrdornin ciprinolin edhe kur mund t\u2019ua rekomandonte mjeku. Kjo p\u00ebr shkak t\u00eb konstatimit t\u00eb efekteve an\u00ebsore q\u00eb linte n\u00eb sh\u00ebndet. Konkretisht n\u00eb shkrimin e botuar t\u00eb dat\u00ebs 16 dhjetor 2013, doktori theksonte se shum\u00eb prej s\u00ebmundjeve t\u00eb traktit urinar trajtoheshin si infeksione urinare t\u00eb p\u00ebrgjithshme pa i precizuar sipas mikrobit aktual q\u00eb ka pacienti.<\/p>\n
\u201cN\u00eb Shqip\u00ebri rezistenca mikrobiale \u00ebsht\u00eb shtuar nga p\u00ebrdorimi pa kriter i antibiotik\u00ebve dhe aq m\u00eb keq, pasi pothuaj 95 p\u00ebr qind e mjek\u00ebve e fillojn\u00eb mjekimin me \u201cciprinol\u201d. Ky antibiotik duhet t\u00eb hiqet fare nga p\u00ebrdorimi p\u00ebr disa vjet q\u00eb t\u00eb \u00e7m\u00ebsohen mikrobet me k\u00ebt\u00eb antibiotik. K\u00ebtu ju b\u00ebj thirrje pacient\u00ebve q\u00eb mos t\u00eb p\u00ebrdorin \u201cCiprinol\u201d edhe kur ua jep mjeku. E r\u00ebnd\u00ebsishme \u00ebsht\u00eb q\u00eb n\u00eb k\u00ebta pacient\u00eb, duhet domosdoshm\u00ebrish t\u00eb mjekohet partnerja seksuale. Automatikisht do t\u00eb thot\u00eb q\u00eb partnerja seksuale (gruaja, e dashura) duhet t\u00eb mjekohet me t\u00eb nj\u00ebjt\u00ebn terapi si mashkulli dhe duhet t\u00eb marrin plus \u201covula vaginale\u201d (Gynexforte) \u00e7do nat\u00eb p\u00ebr aq koh\u00eb sa zgjat mjekimi. Rreth 10 dit\u00eb mbasi mbaron mjekimin duhet patjet\u00ebr t\u00eb p\u00ebrs\u00ebris\u00eb analiz\u00ebn mashkulli. K\u00ebt\u00eb her\u00eb duhet t\u00eb b\u00ebj\u00eb dhe femra analiz\u00ebn (antibiogram\u00ebn) q\u00eb jan\u00eb \u201cstrisho vaginale\u201d dhe \u201csekrecionet uretrale\u201d, deklaronte doktori n\u00eb shkrimin e botuar para disa viteve m\u00eb par\u00eb rreth shqet\u00ebsimeve t\u00eb konfirmuara s\u00eb fundmi nga Agjencia Evropiane e Barnave mbi p\u00ebrdorimin e antibiotik\u00ebve t\u00eb k\u00ebsaj klase.<\/p>\n
Duke iu rikthyer k\u00ebsaj problematike, n\u00eb vijim t\u00eb shkrimit doktori tregon se pse nuk duhet t\u00eb p\u00ebrdoren m\u00eb antibiotik\u00ebt e k\u00ebsaj klase, si dhe rrug\u00ebt se si mund t\u00eb trajtohen nd\u00ebrlikimet sh\u00ebndet\u00ebsore, duke shmangur p\u00ebrdorimin e k\u00ebtyre antibiotik\u00ebve.<\/p>\n
Kur nisi p\u00ebrdorimi i k\u00ebtyre barnave?<\/strong><\/p>\n Konkretisht, pasi filloi demokracia si \u00e7do gj\u00eb, v\u00ebrshuan edhe medikamentet t\u00eb vin\u00eb nga jasht\u00eb, pra edhe antibiotik\u00ebt. Pothuaj nga t\u00eb par\u00ebt ishte edhe ciprinoli, i cili hyn tek ky grup fluorokinolonet, p\u00ebr t\u00eb cilin erdhi edhe lajmi q\u00eb nuk duhet t\u00eb p\u00ebrdoret m\u00eb p\u00ebr shkak t\u00eb efekteve an\u00ebsore q\u00eb shkakton. \u00a0At\u00ebher\u00eb, t\u00eb gjith\u00eb mjek\u00ebt l\u00ebshonin vet\u00ebm receta me ciprinol. Ky antibiotik u keqp\u00ebrdor, u mbip\u00ebrdor deri n\u00eb abuzim. Pas disa vitesh u b\u00eb aq popullor sa ku do q\u00eb t\u00eb shkoje, t\u00eb takoje, t\u00eb bisedoje qoft\u00eb edhe p\u00ebr nj\u00eb shqet\u00ebsim t\u00eb vog\u00ebl, t\u00eb gjith\u00eb t\u00eb rekomandonin ciprinol, i cili n\u00eb vend q\u00eb t\u00eb siguronte efekte n\u00eb sh\u00ebrim, shkaktoi nd\u00ebrlikime. Kjo p\u00ebr shkak t\u00eb keqp\u00ebrdorimit t\u00eb k\u00ebtij antibiotiku.<\/p>\n Kur filluat t\u00eb mendoni p\u00ebr k\u00ebto t\u00eb k\u00ebqija q\u00eb sillte p\u00ebrdorimi i antibiotik\u00ebve t\u00eb k\u00ebsaj klase n\u00eb sh\u00ebndetin e pacient\u00ebve?<\/strong><\/p>\n Fillesa ka qen\u00eb pas vitit 2001, koh\u00eb kur medikamentet urologjike u futen n\u00eb list\u00ebn e rimbursimit. Vura re, n\u00eb pacientet, t\u00eb cil\u00ebt vinin p\u00ebr konsult\u00eb, ata me infeksione urinare t\u00eb p\u00ebrs\u00ebritura, pra t\u00eb kronicizuar kishin p\u00ebrdorur ciprinol. Ky raport erdhi duke u r\u00ebnduar derisa nga 10 pacient\u00eb me infeksione urinare kronike, n\u00eb tet\u00eb prej tyre konstatova se ishte p\u00ebrdorur ky antibiotik. N\u00eb k\u00ebt\u00eb periudh\u00eb fillova t\u00eb alarmohem dhe konstatova nga vizitat q\u00eb kryeja se populli po e p\u00ebrdor ciprinolin si \u201cbuk\u00eb e djath\u00eb\u201d.<\/p>\n Personalisht, kisha koh\u00eb q\u00eb nuk ja u jepja pacient\u00ebve m\u00eb p\u00ebrdorimin e k\u00ebtij antibiotiku duke par\u00eb se gjendja e tyre nuk shfaqte p\u00ebrmir\u00ebsim.<\/p>\n Prof. Kim, a patet presion nga kompanit\u00eb farmaceutike ?<\/strong><\/p>\n Po, por nuk i kam pasur problem presionet e grosisteve tan\u00eb q\u00eb jan\u00eb t\u00eb pangopur dhe nuk ndalen kurr\u00eb edhe kur e shohin q\u00eb medikamentet e tyre po d\u00ebmtojn\u00eb k\u00ebt\u00eb popull t\u00eb varf\u00ebr.<\/p>\n Prof. Kim, sipas t\u00eb dh\u00ebnave t\u00eb konfirmuara, b\u00ebhet me dije se ky grup antibiotikesh mund t\u00eb\u00a0 p\u00ebrdoret vet\u00ebm n\u00eb raste kur nuk ka tjet\u00ebr variant, ju si do e komentoni ?<\/strong><\/p>\n Si fillim po ju sqaroj se ky grup antibiotikesh em\u00ebrtohen Fluorokinolone dhe Kinolone. K\u00ebtu futen: Ciprofloksacin (ciprinol,etj), Gemifloxacin (Factive,etj), Levofloxacin (Levaquin,etj), Norfloxacin (Noroxin,etj), Moxifloxacin (Avelox,etj), Ofloxacin (Floxin,etj). Kryesorja \u00ebsht\u00eb q\u00eb pacientet ta din\u00eb mir\u00eb se duhet t\u00eb m\u00ebsohen me termin brand dhe jo tregtar. Pra duhet ta din\u00eb se nj\u00eb grup brand si\u00e7 \u00ebsht\u00eb ciprofloxacina, ka shume emra tregtare, si\u00e7 jan\u00eb Ciprinoli, etj. E theksova k\u00ebt\u00eb se kam par\u00eb q\u00eb shumica e pacient\u00ebve nuk e dine k\u00ebt\u00eb gj\u00eb, pasi kan\u00eb ardhur tek un\u00eb duke m\u00eb th\u00ebn\u00eb q\u00eb kan\u00eb pir\u00eb tre lloje t\u00eb ndryshme antibiotikesh. Por, n\u00eb fakt ka qen\u00eb vet\u00ebm nj\u00eb lloj antibiotiku, por me emra tregtar t\u00eb ndrysh\u00ebm (k\u00ebta emra vihen sipas qejfit t\u00eb prodhuesit). Tani p\u00ebr t\u2019ju p\u00ebrgjigjur pyetjes po ju them se grupi i ciprofloxacinave (Ciprinoli,etj) nuk duhet t\u00eb p\u00ebrdoren kurr\u00eb, madje edhe n\u00eb rastet kur nuk ka variant tjet\u00ebr. Aq me tep\u00ebr, n\u00eb Shqip\u00ebri, p\u00ebrdorimi i ciprofloxacinave duhet t\u00eb ndalohet kategorikisht, nj\u00eb minimum p\u00ebr 5 vite. Kjo periudhe 5 vje\u00e7are i duhet q\u00eb popullit ton\u00eb t\u2019i zhduket rezistenca mikrobiale ndaj efektit t\u00eb tyre. Ka nj\u00eb grup tjet\u00ebr, i cili p\u00ebrdoret n\u00eb rastet ekstreme, t\u00eb cilin ia rekomandojm\u00eb pacient\u00ebve. Rastet m\u00eb t\u00eb r\u00ebnda ndodhin kur urolog\u00ebt p\u00ebrdorin Ciprofloxacin gjat\u00eb b\u00ebrjes s\u00eb biopsis\u00eb s\u00eb prostat\u00ebs, gjoja p\u00ebr t\u00eb mbrojtur pacientin nga infeksioni. N\u00eb raste t\u00eb tilla shpesh ndodh q\u00eb pacienti t\u00eb kaloj\u00eb n\u00eb gjendje t\u00eb r\u00ebnd septike, e cila \u00ebsht\u00eb gjendja m\u00eb e r\u00ebnd\u00eb q\u00eb ndodh nga infeksionet mikrobiale dhe bakteriale.<\/p>\n A ka ndonj\u00eb tjet\u00ebr antibiotik q\u00eb nuk duhet t\u00eb p\u00ebrdoret pa kriter si\u00e7 ka ndodhur me Ciprinolin?<\/strong><\/p>\n Po ka. Doja t\u00eb thoja se edhe levofloxacina\u00a0 po p\u00ebrdoret si\u00e7 u b\u00eb me Ciprofloxacina. Ka filluar e nj\u00ebjta dukuri si m\u00eb par\u00eb me Ciprinolin. Fatkeq\u00ebsia dhe \u00e7udia m\u00eb e madhe po ndodh me laborator\u00ebt. Mjek\u00ebt dhe pacient\u00ebt duhet t\u00eb nd\u00ebrgjegj\u00ebsohen se ka mbaruar koha kur mund t\u00eb p\u00ebrdoren antibiotiket pa kriter. Duhet q\u00eb levofloxacina t\u00eb mos keqp\u00ebrdoret si\u00e7 u keqp\u00ebrdor Ciprofloxacina, madje m\u00eb e mira \u00ebsht\u00eb q\u00eb mjek\u00ebt t\u00eb jen\u00eb shum\u00eb rigoroz n\u00eb dh\u00ebnien e k\u00ebtij medikamenti. K\u00ebshilloj q\u00eb levofloxacina t\u00eb mos p\u00ebrdoret pa kriter, kjo ve\u00e7an\u00ebrisht n\u00eb rastet kur del se infeksioni ka ndodhur nga mikrobi Eschericia coli.<\/p>\n \u00c7far\u00eb mund t\u00eb k\u00ebshillojm\u00eb n\u00eb k\u00ebto raste p\u00ebr pacient\u00ebt?<\/strong><\/p>\n Fillimisht \u00e7do pacient duhet t\u00eb filloj\u00eb t\u00eb trajtohet me antiseptik\u00eb urine, kryesisht ato me natyr\u00eb bimore. N\u00eb rastet kur nuk qet\u00ebsohet p\u00ebr 2-3 dit\u00eb dhe p\u00ebr me tep\u00ebr kur ka temperatur\u00eb duhet t\u2019i shtohet nj\u00eb antibiotik sipas urokultures-antibiogrames dhe kryesisht sipas eksperienc\u00ebs s\u00eb mjekut, sepse po me ndodh q\u00eb edhe kur ka dal\u00eb n\u00eb analiza se vepron, ky, ose ai antibiotik, prap\u00ebseprap\u00eb nuk me ka dh\u00ebn\u00eb efektin e duhur si\u00e7 e ka dh\u00ebn\u00eb para disa vitesh. Duke u nisur nga kjo po jap edhe porosin\u00eb p\u00ebr laborator\u00ebt. K\u00ebto t\u00eb fundit n\u00eb p\u00ebrgjigje t\u00eb antibiogram\u00eb duhet t\u00eb sh\u00ebnojn\u00eb vet\u00ebm (S)-Sensibel, por si\u00e7 duhet pra kur t\u00eb sh\u00ebnojn\u00eb se ky lloj antibiotiku vepron kund\u00ebr atij mikrobi duhet t\u00eb sh\u00ebnojn\u00eb jo vet\u00ebm + por ++ dhe kur antibiotiku ka veprim m\u00eb t\u00eb fort\u00eb, duhet t\u00eb sh\u00ebnohet me +++. Ky grup antibiotikesh (Fluorokinolone) shkakton edhe probleme t\u00eb tjera mjaft t\u00eb d\u00ebmshme p\u00ebr organizmin.<\/p>\n Konfirmimi nga Agjencia Evropiane e Barnave<\/strong><\/p>\n Ja cilat jan\u00eb efektet e pad\u00ebshiruara nga p\u00ebrdorimi i antibiotik\u00ebve t\u00eb klas\u00ebs s\u00eb flourkinolone<\/strong><\/p>\n Keqp\u00ebrdorimi i antibiotik\u00ebve mbetet ende nj\u00eb problematik\u00eb e mjaft e mpreht\u00eb n\u00eb vendin ton\u00eb. Nj\u00eb gj\u00eb e till\u00eb ka ndodhur edhe me barnat e klas\u00ebs s\u00eb Kinoloneve dhe Flourkinoloneve, p\u00ebr t\u00eb cilat Agjencia Evropiane e Barnave (EMA) ka rivler\u00ebsuar efektet e pad\u00ebshiruara t\u00eb shfaqura n\u00eb sh\u00ebndet nga p\u00ebrdorimi i tyre. P\u00ebrkundrejt vler\u00ebsimeve t\u00eb b\u00ebra, \u00ebsht\u00eb […]<\/p>\n","protected":false},"author":1,"featured_media":1116,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"footnotes":""},"categories":[6,3,18],"tags":[],"yoast_head":"\n\n